UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029036
Receipt number R000033218
Scientific Title Development of the new prognostic markers for breast cancer patients based on immunoresponse monitoring
Date of disclosure of the study information 2017/09/08
Last modified on 2024/09/12 16:56:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of the new prognostic markers for breast cancer patients based on immunoresponse monitoring

Acronym

New prognostic markers for breast cancer patients based on immunoresponse monitoring

Scientific Title

Development of the new prognostic markers for breast cancer patients based on immunoresponse monitoring

Scientific Title:Acronym

New prognostic markers for breast cancer patients based on immunoresponse monitoring

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Immune cells in peripheral blood will be analysed before the treatment to search for prognostic biomarker for breast cancer patients.

Basic objectives2

Others

Basic objectives -Others

Clinicopathological features

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Subset of lymphocytes is investigated using flow cytometry and the relationship with patient outcome will be analysed.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Female

Key inclusion criteria

Breast cancer patients who are going to undergo surgery at our department

Key exclusion criteria

Patients who didn't agree to participate in this study

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Yoshiya
Middle name
Last name Horimoto

Organization

Juntendo University School of Medicine

Division name

Department of Breast Oncology

Zip code

1130033

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Email

yoshiyahorimoto@hotmail.com


Public contact

Name of contact person

1st name Yoshiya
Middle name
Last name Horimoto

Organization

Juntendo University School of Medicine

Division name

Department of Breast Oncology

Zip code

113-0033

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Homepage URL


Email

yoshiyahorimoto@hotmail.com


Sponsor or person

Institute

Juntendo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

-

Address

-

Tel

-

Email

-


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

200

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 09 Month 08 Day

Date of IRB

2015 Year 09 Month 08 Day

Anticipated trial start date

2015 Year 12 Month 21 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2017 Year 09 Month 07 Day

Last modified on

2024 Year 09 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033218